Gerresheimer, a German packaging company, has agreed to sell its Centor business and its global Primary Packaging Plastics unit to Apax Funds for €1.5 billion including debt. The move is part of a broader effort to reduce leverage and move past a period of accounting scrutiny.
What is being sold?
The two plastics units generated roughly €570 million in revenue last year and employ about 2,400 people. They operate 15 production sites across nine countries, plus Centor's US facility. Centor specializes in plastic packaging for pharmaceutical and healthcare products, while the Primary Packaging Plastics unit makes containers and closures for a range of industries.
Gerresheimer launched the process to sell Centor back in February, according to the company, as part of a plan to improve its capital structure. The company expects the deal to "meaningfully" reduce its leverage once completed.
Why is Gerresheimer selling?
The sale comes as Gerresheimer works through accounting scrutiny. The company has been under pressure to clean up its balance sheet and focus on its core glass packaging business, which serves the pharmaceutical and cosmetics industries. By shedding the plastics units, Gerresheimer can concentrate on higher-margin products and reduce debt.
This type of carve-out is common among industrial companies looking to streamline operations. Selling non-core assets can free up cash and management attention, allowing the company to invest more in its main business. For Gerresheimer, the deal also helps address investor concerns about leverage, which had been elevated following previous acquisitions.
What does this mean for investors?
For everyday investors, this deal signals that Gerresheimer is taking steps to strengthen its financial position. Reducing leverage can make the company less risky, as lower debt means less interest expense and more financial flexibility. It also suggests management is focused on improving returns rather than chasing growth through acquisitions.
The sale to Apax, a private equity firm, is a reminder that there is still strong demand for well-run industrial assets. Private equity buyers often see value in businesses that larger companies are willing to part with, especially when those businesses have stable cash flows and global reach.
Investors should watch for how Gerresheimer uses the proceeds from the sale. If the company pays down debt, that could improve its credit rating and lower borrowing costs. If it reinvests in its core glass business, that could boost future growth. The company has not yet detailed its exact plans for the cash.
This deal also fits a broader trend of European industrial companies selling non-core units to refocus. Stellantis recently sold its Free2move car-sharing business to Mutares, and other firms have done similar deals to streamline operations.
What's next?
The transaction is expected to close in the coming months, subject to regulatory approvals and other customary conditions. Once completed, Gerresheimer will be a more focused company, primarily serving the pharmaceutical and cosmetics markets with glass packaging.
For Apax, the acquisition adds a plastics packaging business with a global footprint and a strong customer base. Private equity firms often look to improve efficiency and margins in such businesses before eventually selling them or taking them public.
Investors should keep an eye on Gerresheimer's next earnings report for more details on the deal's impact and the company's updated outlook. The sale could also pave the way for a potential dividend increase or share buyback if the company's financial position improves significantly.
